Eight days ago. Neuren to capture substantially greater value by selecting best commercial outcome after US Phase 3 results in 2021.
Advised by Torreya, Neuren has considered a range of partnering proposals, and has concluded that selecting the optimum commercial outcome after Phase 3 results may capture substantially greater value and is in the best interests of shareholders
Today: Walker sells out.
I would have thought that Neuren/ Treagus would have been aware of Lang's intentions before they issued that announcement on March 17.
So hopefully we are not going to see us taken out on a low ball offer. But who knows "stormy weather"
Ann: Temporary pause in new enrolments for LAVENDER trial in US, page-63
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.54 |
Change
0.100(0.80%) |
Mkt cap ! $1.559B | |||
| Open | High | Low | Value | Volume |
| $12.44 | $12.73 | $12.13 | $11.07M | 885.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1215 | $12.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.54 | 804 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |